Total Payments
$1,164
2022 Payments
$200.00
Companies
11
Transactions
24
Medicare Patients
2,239
Medicare Billing
$232,348
Payment Breakdown by Category
Consulting$550.00 (47.3%)
Food & Beverage$362.76 (31.2%)
Other$240.00 (20.6%)
Education$11.07 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $550.00 | 4 | 47.3% |
| Food and Beverage | $362.76 | 17 | 31.2% |
| Honoraria | $200.00 | 1 | 17.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $40.00 | 1 | 3.4% |
| Education | $11.07 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| COMSORT, Inc | $450.00 | 3 | $0 (2019) |
| Novocure GmbH | $200.00 | 1 | $0 (2022) |
| Janssen Biotech, Inc. | $119.18 | 5 | $0 (2018) |
| GlaxoSmithKline, LLC. | $100.00 | 1 | $0 (2021) |
| Amgen Inc. | $72.14 | 4 | $0 (2017) |
| Shire North American Group Inc | $69.83 | 1 | $0 (2017) |
| GENZYME CORPORATION | $55.46 | 2 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $34.69 | 2 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $33.89 | 3 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $17.21 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $200.00 | 1 | Novocure GmbH ($200.00) |
| 2021 | $111.07 | 2 | GlaxoSmithKline, LLC. ($100.00) |
| 2019 | $190.00 | 2 | COMSORT, Inc ($150.00) |
| 2018 | $57.79 | 3 | Janssen Biotech, Inc. ($24.64) |
| 2017 | $604.97 | 16 | COMSORT, Inc ($300.00) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/19/2022 | Novocure GmbH | — | Honoraria | Cash or cash equivalent | $200.00 | General |
| 10/26/2021 | E.R. Squibb & Sons, L.L.C. | Pomalyst (Drug) | Education | In-kind items and services | $11.07 | General |
| Category: Hematology | ||||||
| 01/15/2021 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $100.00 | General |
| 03/14/2019 | GENZYME CORPORATION | ELITEK (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $40.00 | General |
| Category: ONCOLOGY | ||||||
| 01/18/2019 | COMSORT, Inc | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| Category: ONCOLOGY | ||||||
| 08/16/2018 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: ONCOLOGY | ||||||
| 07/20/2018 | Janssen Biotech, Inc. | Erleada (Drug), DARZALEX | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Oncology | ||||||
| 05/10/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $11.34 | General |
| Category: Oncology | ||||||
| 12/12/2017 | Bayer HealthCare Pharmaceuticals Inc. | Nexavar (Drug), Stivarga, Xofigo | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Oncology | ||||||
| 11/09/2017 | Amgen Inc. | Nplate (Biological), Prolia, XGEVA | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Hematology | ||||||
| 11/07/2017 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2017 | Shire North American Group Inc | FLEXBUMIN (Biological) | Food and Beverage | In-kind items and services | $69.83 | General |
| Category: IMMUNOLOGY | ||||||
| 10/13/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Oncology | ||||||
| 10/03/2017 | Amgen Inc. | Nplate (Biological), Prolia, XGEVA | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Hematology | ||||||
| 09/19/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $11.48 | General |
| Category: Oncology | ||||||
| 08/22/2017 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug), SANDOSTATIN LAR | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: ONCOLOGY | ||||||
| 08/09/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Oncology | ||||||
| 08/08/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: Oncology | ||||||
| 04/25/2017 | Amgen Inc. | Nplate (Biological), XGEVA | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Hematology | ||||||
| 04/11/2017 | Amgen Inc. | Kyprolis (Biological) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Oncology | ||||||
| 03/10/2017 | COMSORT, Inc | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: ONCOLOGY | ||||||
| 03/10/2017 | COMSORT, Inc | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $100.00 | General |
| Category: ONCOLOGY | ||||||
| 02/17/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug), YONDELIS | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Oncology | ||||||
| 01/13/2017 | Janssen Biotech, Inc. | ZYTIGA (Drug), YONDELIS | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 474 | 767 | $246,143 | $44,006 |
| 2022 | 6 | 493 | 910 | $270,262 | $48,791 |
| 2021 | 9 | 697 | 1,069 | $377,614 | $73,768 |
| 2020 | 8 | 575 | 1,053 | $307,274 | $65,784 |
Total Patients
2,239
Total Services
3,799
Medicare Billing
$232,348
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 255 | 463 | $120,537 | $22,498 | 18.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 134 | 218 | $82,259 | $14,326 | 17.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 59 | 59 | $31,803 | $5,533 | 17.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $5,304 | $1,067 | 20.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 14 | 15 | $6,240 | $582.78 | 9.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 288 | 651 | $166,005 | $30,921 | 18.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 69 | 104 | $38,792 | $7,360 | 19.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 61 | 61 | $33,245 | $6,411 | 19.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 43 | 53 | $22,048 | $2,469 | 11.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 18 | $4,284 | $988.37 | 23.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2022 | 21 | 23 | $5,888 | $640.49 | 10.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 265 | 493 | $183,889 | $34,236 | 18.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 247 | 362 | $92,310 | $20,190 | 21.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 43 | 43 | $30,272 | $6,190 | 20.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 32 | 43 | $21,371 | $4,927 | 23.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 24 | 24 | $13,130 | $2,529 | 19.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 36 | 46 | $18,972 | $2,168 | 11.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 16 | 16 | $7,296 | $1,697 | 23.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 14 | 21 | $4,998 | $1,196 | 23.9% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2021 | 20 | 21 | $5,376 | $634.41 | 11.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 316 | 752 | $214,320 | $44,465 | 20.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 54 | 54 | $29,592 | $6,660 | 22.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 42 | 52 | $19,968 | $4,249 | 21.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 26 | 47 | $8,977 | $2,777 | 30.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 50 | 58 | $9,819 | $2,285 | 23.3% |
About Dr. Debra White, M.D
Dr. Debra White, M.D is a Hematology & Oncology healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457339335.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Debra White, M.D has received a total of $1,164 in payments from pharmaceutical and medical device companies, with $200.00 received in 2022. These payments were reported across 24 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($550.00).
As a Medicare-enrolled provider, White has provided services to 2,239 Medicare beneficiaries, totaling 3,799 services with total Medicare billing of $232,348. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Providence, RI
- Active Since 01/03/2006
- Last Updated 03/24/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1457339335
Products in Payments
- KEYTRUDA (Biological) $450.00
- ZYTIGA (Drug) $94.54
- FLEXBUMIN (Biological) $69.83
- Nplate (Biological) $51.31
- ELITEK (Drug) $40.00
- Erleada (Drug) $24.64
- OPDIVO (Biological) $22.82
- TASIGNA (Drug) $21.81
- Kyprolis (Biological) $20.83
- Nexavar (Drug) $17.21
- JEVTANA (Drug) $15.46
- AFINITOR (Drug) $12.88
- Xtandi (Drug) $11.43
- Pomalyst (Drug) $11.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Providence
Ritesh Rathore, Md, MD
Hematology & Oncology — Payments: $324,296
Hematology & Oncology $324,296
Anthony Mega, Md, MD
Hematology & Oncology — Payments: $193,307
Hematology & Oncology $193,307
Dr. Adam Olszewski, M.d, M.D
Hematology & Oncology — Payments: $47,507
Hematology & Oncology $47,507
John Reagan, Md, MD
Hematology & Oncology — Payments: $35,520
Hematology & Oncology $35,520
Hina Khan, M.d, M.D
Hematology & Oncology — Payments: $19,225
Hematology & Oncology $19,225
Dr. Joseph Dibenedetto, Md, MD
Hematology & Oncology — Payments: $6,205
Hematology & Oncology $6,205